Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS ...Middle East

APDS (activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome) is a rare and progressive primary immunodeficiency Joenja® is a targeted treatment of APDS for adult and pediatric patients 12 years of age and older Joenja® is expected to launch in the US in early April Pharming will host...

Hence then, the article about pharming announces us fda approval of joenja leniolisib as the first and only treatment indicated for apds was published today ( Friday 24/03/2023 - 09:52 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS )

Also on site :

• L'ORÉAL PARIS GETS GLAM WITH "THE DEVIL WEARS PRADA 2," DEBUTING OSCARS-NIGHT AD FEATURING KENDALL JENNER AND SIMONE ASHLEY
• Britain will not rejoin EU or set up customs union, Starmer’s top negotiator warns
• 'Honoured to be here': Restored memorial plaque is unveiled at poignant ceremony for fallen soldiers from historic Black Country factory